首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Recent advances in novel heterocyclic scaffolds for the treatment of drug-resistant malaria
【24h】

Recent advances in novel heterocyclic scaffolds for the treatment of drug-resistant malaria

机译:新型杂环支架治疗耐药性疟疾的最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Malaria is a major public health problem all over the world, particularly in tropical and subtropical countries due to the development of resistance and most deadly infection is caused by Plasmodium falciparum. There is a direct need for the discovery of new drugs with unique structures and mechanism of action to treat sensitive and drug-resistant strains of various plasmodia for radical cure of this disease. Traditional compounds such as quinine and related derivatives represent a major source for the development of new drugs. This review presents recent modifications of 4-aminoquinoline and 8-aminoquinolone rings as leads to novel active molecules which are under clinical trials. The review also encompasses the other heterocyclic compounds emerged as potential antimalarial agents with promising results such as acridinediones and acridinone analogues, pyridines and quinolones as antimalarials. Miscellaneous heterocyclics such as tetroxane derivatives, indole derivatives, imidazolopiperazine derivatives, biscationic choline-based compounds and polymer-linked combined antimalarial drugs are also discussed. At last brief introduction to heterocyclics in natural products is also reviewed. Most of them have been under clinical trials and found to be promising in the treatment of drug-resistant strains of Plasmodium and others can be explored for the same purpose.
机译:疟疾是全世界的主要公共卫生问题,特别是在热带和亚热带国家,由于抗药性的发展,而最致命的感染是由恶性疟原虫引起的。直接需要发现具有独特结构和作用机理的新药物,以治疗各种疟原虫的敏感和耐药菌株,以彻底治愈该疾病。传统化合物如奎宁及其相关衍生物是开发新药的主要来源。这篇综述介绍了4-氨基喹啉环和8-氨基喹诺酮环的最新修饰,这些修饰导致了正在临床试验中的新型活性分子。该综述还涵盖了作为潜在抗疟药出现的其他杂环化合物,其结果令人鼓舞,例如as啶二酮和a啶酮类似物,吡啶和喹诺酮类药物为抗疟药。还讨论了其他杂环,如四氧六环衍生物,吲哚衍生物,咪唑并哌嗪衍生物,双阳离子胆碱基化合物和聚合物连接的抗疟药。最后,对天然产物中杂环的简要介绍也进行了综述。它们中的大多数已经在临床试验中,并且发现在治疗疟原虫的耐药菌株中很有前途,并且可以出于相同目的探索其他的菌株。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号